http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113135838-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C243-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C241-04
filingDate 2021-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113135838-B
titleOfInvention A kind of method of continuous flow synthesis benserazide hydrochloride
abstract The invention belongs to the technical field of drug preparation, and in particular relates to a preparation method for continuous flow synthesis of benserazide hydrochloride. The method includes the following steps: S1: transporting the ethanol solution of the starting material hydrazide hydrochloride to the heat exchanger, and then entering the reactor, and also transporting the ethanol solution of trihydroxybenzaldehyde to the reactor, and reacting to obtain hydrochloric acid The ethanol suspension of benzyl hydrazone; S2: the ethanol suspension of benzyl hydrazone hydrochloride enters another reactor, and hydrogen is passed into the reactor at the same time; S3: after the reaction solution is continuously collected, the organic phase is concentrated under reduced pressure, Ethanol was recovered to obtain crude product. The benserazide hydrochloride synthesized by the continuous flow reaction method of the present invention has a maximum yield of about 88%, and a maximum purity of about 99.7%, which reduces the impurity B generated by the excessive reaction, and the content of the impurity B is only 0.23%, Far below the 0.5% required by the Pharmacopoeia. In addition, the method of the present invention is simple to operate, easy to industrialize production, and at the same time occupies a small area and has low operation cost.
priorityDate 2021-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112028788-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448654791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420605406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449815480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21887872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75064

Total number of triples: 40.